{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:48:34Z","timestamp":1790844514091,"version":"4.1.0"},"reference-count":288,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T00:00:00Z","timestamp":1600387200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"National Institute of Pharmaceutical Education and Research"},{"name":"Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.biopha.2020.110776","type":"journal-article","created":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T11:52:49Z","timestamp":1601725969000},"page":"110776","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"special_numbering":"C","title":["Anxiety: An ignored aspect of Parkinson\u2019s disease lacking attention"],"prefix":"10.1016","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7066-7706","authenticated-orcid":false,"given":"Dharmendra Kumar","family":"Khatri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamta","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anika","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashi Bala","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.biopha.2020.110776_bib0005","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1176\/jnp.14.2.223","article-title":"An essay on the shaking palsy","volume":"14","author":"Parkinson","year":"2002","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.biopha.2020.110776_bib0010","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.neubiorev.2018.10.004","article-title":"The hidden side of Parkinson\u2019s disease: studying pain, anxiety and depression in animal models","volume":"96","author":"Faivre","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"11","key":"10.1016\/j.biopha.2020.110776_bib0015","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S1474-4422(18)30355-7","article-title":"The burden of Parkinson\u2019s disease: a worldwide perspective","volume":"17","author":"Rocca","year":"2018","journal-title":"Lancet Neurol."},{"issue":"11","key":"10.1016\/j.biopha.2020.110776_bib0020","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","article-title":"Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"17","author":"Dorsey","year":"2018","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110776_bib0025","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3390\/ijms18030551","article-title":"Parkinson\u2019s disease: from pathogenesis to pharmacogenomics","volume":"18","author":"Cacabelos","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2020.110776_bib0030","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.neurobiolaging.2005.08.012","article-title":"Protein aggregation in the pathogenesis of familial and sporadic Parkinson\u2019s disease","volume":"27","author":"McNaught","year":"2006","journal-title":"Neurobiol. Aging"},{"issue":"10 suppl 4","key":"10.1016\/j.biopha.2020.110776_bib0035","first-page":"S24","article-title":"The pathogenesis of cell death in Parkinson\u2019s disease","volume":"66","author":"Jenner","year":"2006","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.biopha.2020.110776_bib0040","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.parkreldis.2007.06.011","article-title":"Anxiety and depression: main determinants of health-related quality of life in Brazilian patients with Parkinson\u2019s disease","volume":"14","author":"Carod-Artal","year":"2008","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.biopha.2020.110776_bib0045","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.neubiorev.2016.07.010","article-title":"Motor symptoms in Parkinson\u2019s disease: a unified framework","volume":"68","author":"Moustafa","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.biopha.2020.110776_bib0050","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pbb.2016.09.002","article-title":"Neuroprotective effect of curcumin as evinced by abrogation of rotenone-induced motor deficits, oxidative and mitochondrial dysfunctions in mouse model of Parkinson\u2019s disease","volume":"150","author":"Khatri","year":"2016","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"S3","key":"10.1016\/j.biopha.2020.110776_bib0055","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1002\/ana.10487","article-title":"Genetic and environmental factors in the cause of Parkinson\u2019s disease","volume":"53","author":"Warner","year":"2003","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.biopha.2020.110776_bib0060","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/01.wco.0000170951.08924.3d","article-title":"Genetics of Parkinson\u2019s disease","volume":"18","author":"Gasser","year":"2005","journal-title":"Curr. Opin. Neurol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110776_bib0065","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.tox.2012.06.007","article-title":"Induction of apoptotic erythrocyte death by rotenone","volume":"300","author":"Lupescu","year":"2012","journal-title":"Toxicology"},{"issue":"6","key":"10.1016\/j.biopha.2020.110776_bib0070","doi-asserted-by":"crossref","first-page":"737","DOI":"10.4103\/0253-7613.103275","article-title":"Neuroprotective activity of Stereospermum suaveolens DC against 6-OHDA induced Parkinson\u2019s disease model","volume":"44","author":"Shalavadi","year":"2012","journal-title":"Indian J. Pharmacol."},{"key":"10.1016\/j.biopha.2020.110776_bib0075","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1749-6632.2003.tb07477.x","article-title":"Pathophysiology of Parkinson\u2019s disease: the MPTP primate model of the human disorder","volume":"991","author":"Wichmann","year":"2003","journal-title":"Anal. N Y Acad. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2020.110776_bib0080","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1023\/A:1009616228304","article-title":"Role of reactive oxygen species (ROS) in apoptosis induction","volume":"5","author":"Simon","year":"2000","journal-title":"Apoptosis"},{"key":"10.1016\/j.biopha.2020.110776_bib0085","first-page":"37","article-title":"Biochemistry of reactive oxygen and nitrogen species","volume":"3","author":"Ozcan","year":"2015","journal-title":"Basic Principles Clin. Significance Oxidative Stress"},{"issue":"4","key":"10.1016\/j.biopha.2020.110776_bib0090","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JPD-130230","article-title":"The role of oxidative stress in Parkinson\u2019s disease","volume":"3","author":"Dias","year":"2013","journal-title":"J. Parkinsons Dis."},{"issue":"10","key":"10.1016\/j.biopha.2020.110776_bib0095","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1089\/neu.2000.17.843","article-title":"Mitochondrial participation in ischemic and traumatic neural cell death","volume":"17","author":"Fiskum","year":"2000","journal-title":"J. Neurotrauma"},{"issue":"8","key":"10.1016\/j.biopha.2020.110776_bib0100","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.3390\/molecules24081583","article-title":"Oxidative stress: a key modulator in neurodegenerative diseases","volume":"24","author":"Singh","year":"2019","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.biopha.2020.110776_bib0105","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1016\/j.bbamcr.2016.09.012","article-title":"Activation of apoptosis signalling pathways by reactive oxygen species","volume":"1863","author":"Redza-Dutordoir","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.biopha.2020.110776_bib0110","first-page":"1817","article-title":"Damage to dopaminergic neurons by oxidative stress in Parkinson\u2019s disease","volume":"41","author":"Guo","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.biopha.2020.110776_bib0115","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1749-6632.2003.tb07469.x","article-title":"Mitochondrial mechanisms of neural cell death and neuroprotective interventions in Parkinson\u2019s disease","volume":"991","author":"Fiskum","year":"2003","journal-title":"Anal. N Y Acad. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2020.110776_bib0120","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009332","article-title":"Mitochondrial biology and Parkinson\u2019s disease","volume":"2","author":"Perier","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"20","key":"10.1016\/j.biopha.2020.110776_bib0125","doi-asserted-by":"crossref","first-page":"8145","DOI":"10.1523\/JNEUROSCI.18-20-08145.1998","article-title":"1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing Bcl-2","volume":"18","author":"Yang","year":"1998","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.biopha.2020.110776_bib0130","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.4103\/1673-5374.235076","article-title":"Differences in brain pathological changes between rotenone and 6-hydroxydopamine Parkinson\u2019s disease models","volume":"13","author":"Liu","year":"2018","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.biopha.2020.110776_bib0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101377","article-title":"A functionalized hydroxydopamine quinone links thiol modification to neuronal cell death","volume":"28","author":"Farzam","year":"2020","journal-title":"Redox Biol."},{"issue":"3989","key":"10.1016\/j.biopha.2020.110776_bib0140","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1126\/science.172.3989.1257","article-title":"Inhibition of biogenic amine uptake by hydrogen peroxide: a mechanism for toxic effects of 6-hydroxydopamine","volume":"172","author":"Heikiila","year":"1971","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.biopha.2020.110776_bib0145","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","article-title":"The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson\u2019s disease","volume":"85","author":"Pickrell","year":"2015","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.biopha.2020.110776_bib0150","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neulet.2012.06.062","article-title":"PARK2 gene mutations in early onset Parkinson\u2019s disease patients of South India","volume":"523","author":"Padmaja","year":"2012","journal-title":"Neurosci. Lett."},{"issue":"11","key":"10.1016\/j.biopha.2020.110776_bib0155","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1007\/s10495-010-0486-8","article-title":"The regulatory role of \u03b1-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson\u2019s disease","volume":"15","author":"Yasuda","year":"2010","journal-title":"Apoptosis"},{"issue":"7","key":"10.1016\/j.biopha.2020.110776_bib0160","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1172\/JCI29178","article-title":"Diagnosis and treatment of Parkinson disease: molecules to medicine","volume":"116","author":"Savitt","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.biopha.2020.110776_bib0165","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/emmm.200900024","article-title":"PINK1 function in health and disease","volume":"1","author":"Deas","year":"2009","journal-title":"EMBO Mol. Med."},{"issue":"51","key":"10.1016\/j.biopha.2020.110776_bib0170","doi-asserted-by":"crossref","first-page":"39718","DOI":"10.1074\/jbc.M110.137034","article-title":"Human DJ-1-specific transcriptional activation of tyrosine hydroxylase gene","volume":"285","author":"Ishikawa","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2020.110776_bib0175","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/683920","article-title":"Neuroprotective function of DJ-1 in Parkinson\u2019s disease","volume":"2013","author":"Ariga","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2020.110776_bib0180","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.parkreldis.2016.04.024","article-title":"Early onset Parkinson\u2019s disease due to DJ1 mutations: an Indian study","volume":"32","author":"Abbas","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"issue":"20","key":"10.1016\/j.biopha.2020.110776_bib0185","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1056\/NEJM200005183422004","article-title":"A five-year study of the incidence of dyskinesia in patients with early Parkinson\u2019s disease who were treated with ropinirole or levodopa","volume":"342","author":"Rascol","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.biopha.2020.110776_bib0190","first-page":"1044","article-title":"Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial","volume":"61","author":"Holloway","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.biopha.2020.110776_bib0195","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neubiorev.2018.05.021","article-title":"A new outlook on cholinergic interneurons in Parkinson\u2019s disease and L-DOPA-induced dyskinesia","volume":"92","author":"Conti","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"7","key":"10.1016\/j.biopha.2020.110776_bib0200","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.tips.2005.05.002","article-title":"The \u2018magic\u2019of L-dopa: why is it the gold standard Parkinson\u2019s disease therapy?","volume":"26","author":"Mercuri","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2020.110776_bib0205","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3390\/toxics3010075","article-title":"L-Dopa and Brain Serotonin System Dysfunction","volume":"3","author":"Stansley","year":"2015","journal-title":"Toxics"},{"issue":"3","key":"10.1016\/j.biopha.2020.110776_bib0210","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1755-5949.2010.00142.x","article-title":"Acetylcholine-dopamine interactions in the pathophysiology and treatment of CNS disorders","volume":"16","author":"Lester","year":"2010","journal-title":"CNS Neurosci. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2020.110776_bib0215","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1749-6632.2000.tb06191.x","article-title":"Effect of MAO\u2010B inhibitors on MPP+ toxicity in vivo","volume":"899","author":"Wu","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.biopha.2020.110776_bib0220","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3389\/fphar.2016.00340","article-title":"Inhibitors of MAO-A and MAO-B in psychiatry and neurology","volume":"7","author":"Finberg","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2020.110776_bib0225","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/mdc3.12507","article-title":"Management of depression in parkinson\u2019s disease: a systematic review","volume":"4","author":"Starkstein","year":"2017","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"3","key":"10.1016\/j.biopha.2020.110776_bib0230","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1046\/j.1471-4159.1999.0731033.x","article-title":"Role of serotonin2A and serotonin2B\/2C receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation","volume":"73","author":"De Deurwaerd\u00e8re","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2020.110776_bib0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1468-1331.9.s3.1.x","article-title":"5\u2010hydroxytryptamine (5\u2010HT, serotonin) and Parkinson\u2019s disease\u2013opportunities for novel therapeutics to reduce the problems of levodopa therapy","volume":"9","author":"Nicholson","year":"2002","journal-title":"Eur. J. Neurol."},{"issue":"4","key":"10.1016\/j.biopha.2020.110776_bib0240","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/1098-2396(20010315)39:4<288::AID-SYN1011>3.0.CO;2-V","article-title":"Serotonin 5\u2010HT1A receptor expression is selectively enhanced in the striosomal compartment of chronic parkinsonian monkeys","volume":"39","author":"Frechilla","year":"2001","journal-title":"Synapse"},{"issue":"6","key":"10.1016\/j.biopha.2020.110776_bib0245","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/1531-8257(200011)15:6<1064::AID-MDS1002>3.0.CO;2-C","article-title":"5\u2010HT2C receptor binding is increased in the substantia nigra pars reticulata in Parkinson\u2019s disease","volume":"15","author":"Fox","year":"2000","journal-title":"Movement Disorders"},{"issue":"Pt 12","key":"10.1016\/j.biopha.2020.110776_bib0250","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1093\/brain\/awn235","article-title":"Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia","volume":"131","author":"Munoz","year":"2008","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.biopha.2020.110776_bib0255","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2174\/187152709789824606","article-title":"Glutamate receptors as therapeutic targets for Parkinson\u2019s disease","volume":"8","author":"Johnson","year":"2009","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"7","key":"10.1016\/j.biopha.2020.110776_bib0260","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.bbadis.2008.09.009","article-title":"Targets for neuroprotection in Parkinson\u2019s disease","volume":"1792","author":"Yacoubian","year":"2009","journal-title":"Biochimica et biophysica acta (BBA)-Molecular basis of disease"},{"issue":"7","key":"10.1016\/j.biopha.2020.110776_bib0265","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.parkreldis.2006.04.005","article-title":"Molecular pathogenesis of Parkinson\u2019s disease: identification of mutations in the Parkin gene in Indian patients","volume":"12","author":"Biswas","year":"2006","journal-title":"Parkinsonism Relat. Disord."},{"issue":"11","key":"10.1016\/j.biopha.2020.110776_bib0270","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/brain\/124.11.2131","article-title":"Pathophysiology of bradykinesia in Parkinson\u2019s disease","volume":"124","author":"Berardelli","year":"2001","journal-title":"Brain: J. Neurol."},{"key":"10.1016\/j.biopha.2020.110776_bib0275","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.32.5.514","article-title":"The mysterious motor function of the basal ganglia: the Robert Wartenberg Lecture","author":"Marsden","year":"1982","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.biopha.2020.110776_bib0280","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1749-6632.1992.tb24523.x","article-title":"Midbrain dopaminergic cell loss in parkinson\u2019s disease and MPTP\u2010Induced parkinsonism: sparing of Calbindin\u2010D25k\u2014containing cells a","volume":"648","author":"German","year":"1992","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2020.110776_bib0285","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/jnnp.46.1.35","article-title":"The behaviour of the long-latency stretch reflex in patients with Parkinson\u2019s disease, Journal of Neurology","volume":"46","author":"Rothwell","year":"1983","journal-title":"Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.biopha.2020.110776_bib0290","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/brain\/106.4.1001","article-title":"The correlation between tremor characteristics and the predicted volume of effective lesions in stereotaxic nucleus ventralis intermedius thalamotomy","volume":"106","author":"Hirai","year":"1983","journal-title":"Brain: J. Neurol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110776_bib0295","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1523\/JNEUROSCI.3388-07.2008","article-title":"Low-Pass filter properties of basal ganglia\u2013cortical\u2013muscle loops in the normal and MPTP primate model of Parkinsonism","volume":"28","author":"Rivlin-Etzion","year":"2008","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.biopha.2020.110776_bib0300","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0166-2236(02)02235-X","article-title":"Move to the rhythm: oscillations in the subthalamic nucleus\u2013external globus pallidus network","volume":"25","author":"Bevan","year":"2002","journal-title":"Trends Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2020.110776_bib0305","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1136\/jnnp.46.1.45","article-title":"Physiological mechanisms of rigidity in Parkinson\u2019s disease","volume":"46","author":"Berardelli","year":"1983","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"12","key":"10.1016\/j.biopha.2020.110776_bib0310","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S1474-4422(09)70293-5","article-title":"Initial clinical manifestations of Parkinson\u2019s disease: features and pathophysiological mechanisms","volume":"8","author":"Rodriguez-Oroz","year":"2009","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.biopha.2020.110776_bib0315","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/mds.23696","article-title":"A tale on animal models of Parkinson\u2019s disease","volume":"26","author":"Bezard","year":"2011","journal-title":"Mov. Disord."},{"issue":"8","key":"10.1016\/j.biopha.2020.110776_bib0320","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/mds.21524","article-title":"Enhancement of rigidity in Parkinson\u2019s disease with activation","volume":"22","author":"Hong","year":"2007","journal-title":"Mov. Disord."},{"issue":"15","key":"10.1016\/j.biopha.2020.110776_bib0325","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1002\/mds.21685","article-title":"Patients with adult\u2010onset dystonic tremor resembling parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs)","volume":"22","author":"Schneider","year":"2007","journal-title":"Movement Disorders"},{"issue":"5","key":"10.1016\/j.biopha.2020.110776_bib0330","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.4103\/neuroindia.NI_880_16","article-title":"Review of tremor in Parkinson\u2019s disease and atypical parkinsonian disorders","volume":"65","author":"Mailankody","year":"2017","journal-title":"Neurol. India"},{"issue":"4","key":"10.1016\/j.biopha.2020.110776_bib0335","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson\u2019s disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J. Neuro. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.biopha.2020.110776_bib0340","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1212\/01.WNL.0000031424.51127.2B","article-title":"Tremor in Parkinson\u2019s disease and serotonergic dysfunction: an 11C-WAY 100635 PET study","volume":"60","author":"Doder","year":"2003","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.biopha.2020.110776_bib0345","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1093\/brain\/aws023","article-title":"Cerebral causes and consequences of parkinsonian resting tremor: a tale of two circuits?","volume":"135","author":"Helmich","year":"2012","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.biopha.2020.110776_bib0350","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0966-6362(00)00076-X","article-title":"Postural instability in Parkinson\u2019s disease: a comparison with and without a concurrent task","volume":"12","author":"Morris","year":"2000","journal-title":"Gait Posture"},{"key":"10.1016\/j.biopha.2020.110776_bib0355","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.neubiorev.2018.08.008","article-title":"Balancing between the two: Are freezing of gait and postural instability in Parkinson\u2019s disease connected?","volume":"94","author":"Bekkers","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"9","key":"10.1016\/j.biopha.2020.110776_bib0360","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/mds.21015","article-title":"Balance in Parkinson\u2019s disease under static and dynamic conditions","volume":"21","author":"Nardone","year":"2006","journal-title":"Movement Disorders"},{"key":"10.1016\/j.biopha.2020.110776_bib0365","series-title":"Postural orientation and equilibrium","author":"Horak","year":"1996"},{"issue":"9","key":"10.1016\/j.biopha.2020.110776_bib0370","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.37.9.1539","article-title":"Does long\u2010term aggravation of Parkinson\u2019s disease result from nondopaminergic lesions?","volume":"37","author":"Bonnet","year":"1987","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.biopha.2020.110776_bib0375","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/cne.901870405","article-title":"Regional topography within noradrenergic locus coeruleus as revealed by retrograde transport of horseradish peroxidase","volume":"187","author":"Mason","year":"1979","journal-title":"J. Comp. Neurol."},{"issue":"6","key":"10.1016\/j.biopha.2020.110776_bib0380","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1152\/jn.1996.75.6.2380","article-title":"Effects of dopamine on postural control in parkinsonian subjects: scaling, set, and tone","volume":"75","author":"Horak","year":"1996","journal-title":"J. Neurophysiol."},{"issue":"5","key":"10.1016\/j.biopha.2020.110776_bib0385","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/mds.870110506","article-title":"Influence of dopaminergic medication on automatic postural responses and balance impairment in Parkinson\u2019s disease","volume":"11","author":"Bloem","year":"1996","journal-title":"Movement Disorders"},{"issue":"2","key":"10.1016\/j.biopha.2020.110776_bib0390","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1176\/jnp.17.2.214","article-title":"Anhedonia, depression, and motor functioning in Parkinson\u2019s disease during treatment with pramipexole","volume":"17","author":"Lemke","year":"2005","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.biopha.2020.110776_bib0395","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1017\/S0033291715002196","article-title":"Anxiety and anxious-depression in Parkinson\u2019s disease over a 4-year period: a latent transition analysis","volume":"46","author":"Landau","year":"2016","journal-title":"Psychol. Med."},{"issue":"2","key":"10.1016\/j.biopha.2020.110776_bib0400","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.1176\/appi.neuropsych.14030055","article-title":"ON-OFF effects of dopaminergic therapy on psychiatric symptoms in parkinson\u2019s disease","volume":"27","author":"Ganjavi","year":"2015","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"12","key":"10.1016\/j.biopha.2020.110776_bib0405","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11910-013-0409-5","article-title":"Depression and Parkinson\u2019s disease: current knowledge","volume":"13","author":"Marsh","year":"2013","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2020.110776_bib0410","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/brain\/awh445","article-title":"Depression in Parkinson\u2019s disease: loss of dopamine and noradrenaline innervation in the limbic system","volume":"128","author":"Remy","year":"2005","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.biopha.2020.110776_bib0415","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1590\/S1516-44462003000400010","article-title":"Update on stress and depression: the role of the hypothalamic-pituitary-adrenal (HPA) axis","volume":"25","author":"Mello","year":"2003","journal-title":"Rev. Bras. Psiquiatr."},{"issue":"1","key":"10.1016\/j.biopha.2020.110776_bib0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/a0038550","article-title":"A brief history of the development of antidepressant drugs: from monoamines to glutamate","volume":"23","author":"Hillhouse","year":"2015","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.biopha.2020.110776_bib0425","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.neubiorev.2016.06.028","article-title":"Effects of experimental sleep deprivation on anxiety-like behavior in animal research: systematic review and meta-analysis","volume":"68","author":"Pires","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"5","key":"10.1016\/j.biopha.2020.110776_bib0430","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/jnnp.2006.100370","article-title":"Insomnia in Parkinson\u2019s disease: frequency and progression over time","volume":"78","author":"Gjerstad","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.biopha.2020.110776_bib0435","series-title":"Emerging Views of Dopamine in Modulating sleep\/wake State from an Unlikely Source: PD","author":"Rye","year":"2002"},{"issue":"5","key":"10.1016\/j.biopha.2020.110776_bib0440","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1365-2125.1987.tb03223.x","article-title":"Parkinson\u2019s disease in the elderly: response to and optimal spacing of night time dosing with levodopa","volume":"24","author":"Leeman","year":"1987","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"10","key":"10.1016\/j.biopha.2020.110776_bib0445","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/00019442-200510000-00003","article-title":"Psychiatric complications in Parkinson disease","volume":"13","author":"Weintraub","year":"2005","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.biopha.2020.110776_bib0450","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.neubiorev.2017.07.014","article-title":"Contribution of language studies to the understanding of cognitive impairment and its progression over time in Parkinson\u2019s disease","volume":"80","author":"Auclair-Ouellet","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3","key":"10.1016\/j.biopha.2020.110776_bib0455","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/archneur.60.3.387","article-title":"Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study","volume":"60","author":"Aarsland","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.biopha.2020.110776_bib0460","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41531-018-0055-3","article-title":"Cognitive impairment in Parkinson\u2019s disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health","volume":"4","author":"Goldman","year":"2018","journal-title":"NPJ Parkinsons Dis."},{"issue":"S6","key":"10.1016\/j.biopha.2020.110776_bib0465","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/mds.10565","article-title":"What causes mental dysfunction in Parkinson\u2019s disease?","volume":"18","author":"Emre","year":"2003","journal-title":"Movement Disorders"},{"issue":"3","key":"10.1016\/j.biopha.2020.110776_bib0470","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/brain\/awf052","article-title":"Dopaminergic modulation of high\u2010level cognition in Parkinson\u2019s disease: the role of the prefrontal cortex revealed by PET","volume":"125","author":"Cools","year":"2002","journal-title":"Brain J. Neurol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110776_bib0475","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/ana.10078","article-title":"Dopaminergic modulation of cortical function in patients with Parkinson\u2019s disease","volume":"51","author":"Mattay","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.biopha.2020.110776_bib0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neubiorev.2018.08.004","article-title":"\u201cPure apathy\u201d and cognitive dysfunctions in Parkinson\u2019s disease: a meta-analytic study","volume":"94","author":"D\u2019Iorio","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"suppl 5","key":"10.1016\/j.biopha.2020.110776_bib0485","first-page":"S1","article-title":"An algorithm (decision tree) for the management of Parkinson\u2019s disease (2001):: treatment Guidelines","volume":"56","author":"Olanow","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2020.110776_bib0490","series-title":"Autonomic Complications of Parkinson\u2019s Disease, Parkinson\u2019s Disease and Movement Disorders","first-page":"161","author":"Hiner","year":"2000"},{"key":"10.1016\/j.biopha.2020.110776_bib0495","article-title":"Orthostatic hypotension in patients with Parkinson\u2019s disease and atypical parkinsonism","volume":"2014","author":"Fereshtehnejad","year":"2014","journal-title":"Parkinsons Dis."},{"issue":"10","key":"10.1016\/j.biopha.2020.110776_bib0500","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1001\/archneur.60.10.1400","article-title":"Orthostatic hypotension in de novo Parkinson disease","volume":"60","author":"Bonuccelli","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.biopha.2020.110776_bib0505","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fneur.2013.00064","article-title":"The management of orthostatic hypotension in Parkinson\u2019s disease","volume":"4","author":"Sanchez-Ferro","year":"2013","journal-title":"Front. Neurol."},{"key":"10.1016\/j.biopha.2020.110776_bib0510","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41531-018-0042-8","article-title":"Management of constipation in patients with Parkinson\u2019s disease","volume":"4","author":"Pedrosa Carrasco","year":"2018","journal-title":"NPJ Parkinsons Dis."},{"issue":"1","key":"10.1016\/j.biopha.2020.110776_bib0515","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1055\/s-0032-1301754","article-title":"Medical management of constipation","volume":"25","author":"Portalatin","year":"2012","journal-title":"Clin. Colon Rectal Surg."},{"issue":"2","key":"10.1016\/j.biopha.2020.110776_bib0520","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/00926230490258893","article-title":"Sexual dysfunction in Parkinson\u2019s disease","volume":"30","author":"Bronner","year":"2004","journal-title":"J. Sex Marital Ther."},{"issue":"6","key":"10.1016\/j.biopha.2020.110776_bib0525","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/1756285611411504","article-title":"Management of sexual dysfunction in Parkinson\u2019s disease","volume":"4","author":"Bronner","year":"2011","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"12","key":"10.1016\/j.biopha.2020.110776_bib0530","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1002\/mds.10586","article-title":"Sweating dysfunction in Parkinson\u2019s disease","volume":"18","author":"Swinn","year":"2003","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.biopha.2020.110776_bib0535","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","article-title":"Non-motor symptoms of Parkinson\u2019s disease: dopaminergic pathophysiology and treatment","volume":"8","author":"Chaudhuri","year":"2009","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110776_bib0540","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.36.1.73","article-title":"Autonomic dysfunction in Parkinson\u2019s disease","volume":"36","author":"Goetz","year":"1986","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.biopha.2020.110776_bib0545","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0304-3959(94)00172-B","article-title":"The role of the basal ganglia in nociception and pain","volume":"60","author":"Chudler","year":"1995","journal-title":"Pain"},{"key":"10.1016\/j.biopha.2020.110776_bib0550","series-title":"Neurophysiological, Pharmacological and Behavioral Evidence for Medial Thalamic Mediation of Cocaine-induced Dopaminergic Analgesia","author":"Shyu","year":"1992"},{"key":"10.1016\/j.biopha.2020.110776_bib0555","article-title":"Classification and characteristics of pain associated with Parkinson\u2019s disease","volume":"2016","author":"Blood","year":"2016","journal-title":"Parkinsons Dis."},{"issue":"4","key":"10.1016\/j.biopha.2020.110776_bib0560","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1590\/0101-60830000000126","article-title":"Can anxiety increase tremors in patients with Parkinson\u2019s disease? An experimental model","volume":"44","author":"Chagas","year":"2017","journal-title":"Archives Clin. Psychiatry (S\u00e3o Paulo)"},{"issue":"3","key":"10.1016\/j.biopha.2020.110776_bib0565","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1353-8020(01)00015-3","article-title":"Non-recognition of depression and other non-motor symptoms in Parkinson\u2019s disease","volume":"8","author":"Shulman","year":"2002","journal-title":"Parkinsonism Relat. Disord."},{"issue":"7","key":"10.1016\/j.biopha.2020.110776_bib0570","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0006-3223(93)90237-8","article-title":"Parkinson\u2019s disease and anxiety: comorbidity with depression","volume":"34","author":"Menza","year":"1993","journal-title":"Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.biopha.2020.110776_bib0575","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.parkreldis.2004.01.008","article-title":"Environmental factors and Parkinson\u2019s disease: a case\u2013control study in the Tuscany region of Italy","volume":"10","author":"Nuti","year":"2004","journal-title":"Parkinsonism Relat. Disord."},{"issue":"1","key":"10.1016\/j.biopha.2020.110776_bib0580","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1600-0404.1993.tb04068.x","article-title":"\u201cPanic attacks\u201d in Parkinson\u2019s disease: a long\u2010term complication of levodopatherapy","volume":"87","author":"V\u00e1zquez","year":"1993","journal-title":"Acta Neurol. Scand."},{"issue":"S3","key":"10.1016\/j.biopha.2020.110776_bib0585","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1002\/mds.23884","article-title":"The Movement Disorder Society evidence\u2010based medicine review update: treatments for the non\u2010motor symptoms of Parkinson\u2019s disease","volume":"26","author":"Seppi","year":"2011","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.biopha.2020.110776_bib0590","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(16)30328-3","article-title":"Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson\u2019s disease: a cohort study","volume":"16","author":"Schrag","year":"2017","journal-title":"Lancet Neurol."},{"issue":"10","key":"10.1016\/j.biopha.2020.110776_bib0595","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11920-016-0730-1","article-title":"Current understanding of psychosis in Parkinson\u2019s disease","volume":"18","author":"Ojo","year":"2016","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.biopha.2020.110776_bib0600","article-title":"Anxiety disorders in patients with Parkinson\u2019s disease","author":"Stein","year":"1990","journal-title":"Am. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.biopha.2020.110776_bib0605","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1176\/ajp.145.8.1020","article-title":"Evidence for atypical depression in Parkinson\u2019s disease","volume":"145","author":"Schiffer","year":"1988","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.biopha.2020.110776_bib0610","series-title":"Behavioral Neurobiology of Anxiety and its Treatment","first-page":"21","article-title":"Epidemiology of anxiety disorders","author":"Kessler","year":"2009"},{"issue":"6","key":"10.1016\/j.biopha.2020.110776_bib0615","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","article-title":"Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"issue":"8","key":"10.1016\/j.biopha.2020.110776_bib0620","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.brat.2005.08.013","article-title":"Psychometric properties of the social phobia inventory: further evaluation","volume":"44","author":"Antony","year":"2006","journal-title":"Behav. Res. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2020.110776_bib0625","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1080\/15374416.2015.1079779","article-title":"Developmental differences in functioning in youth with social phobia","volume":"46","author":"Hoff","year":"2017","journal-title":"J. Clin. Child Adolesc. Psychol."},{"issue":"7","key":"10.1016\/j.biopha.2020.110776_bib0630","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180298","article-title":"The moderating role of avoidance behavior on anxiety over time: Is there a difference between social anxiety disorder and specific phobia?","volume":"12","author":"Rudaz","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biopha.2020.110776_bib0635","first-page":"257","article-title":"Obsessive-compulsive disorder","volume":"37","author":"Goodman","year":"2014","journal-title":"Psychiatric Clinics"},{"issue":"4","key":"10.1016\/j.biopha.2020.110776_bib0640","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/da.20488","article-title":"Where does obsessive\u2013compulsive disorder belong in DSM\u2010V?","volume":"25","author":"Storch","year":"2008","journal-title":"Depress. Anxiety"},{"issue":"6","key":"10.1016\/j.biopha.2020.110776_bib0645","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0893-133X(01)00310-4","article-title":"Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims","volume":"25","author":"Arango","year":"2001","journal-title":"Neuropsychopharmacology"},{"issue":"25","key":"10.1016\/j.biopha.2020.110776_bib0650","doi-asserted-by":"crossref","first-page":"8788","DOI":"10.1523\/JNEUROSCI.23-25-08788.2003","article-title":"Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide","volume":"23","author":"Lemonde","year":"2003","journal-title":"J. Neurosci."},{"issue":"Pt 9","key":"10.1016\/j.biopha.2020.110776_bib0655","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1093\/brain\/aww190","article-title":"Serotonergic loss underlying apathy in Parkinson\u2019s disease","volume":"139","author":"Schrag","year":"2016","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.biopha.2020.110776_bib0660","article-title":"The comparative efficacy of buspirone and diazepam in the treatment of anxiety","author":"Goldberg","year":"1979","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.biopha.2020.110776_bib0665","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00213-013-3389-x","article-title":"P5-HT 1A receptors in mood and anxiety: recent insights into autoreceptor versus heteroreceptor function","volume":"231","author":"Garcia-Garcia","year":"2014","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1016\/j.biopha.2020.110776_bib0670","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1017\/S1461145705005900","article-title":"Clozapine and olanzapine, but not haloperidol, suppress serotonin efflux in the medial prefrontal cortex elicited by phencyclidine and ketamine","volume":"9","author":"Amarg\u00f3s-Bosch","year":"2006","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2020.110776_bib0675","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0166-4328(96)00071-X","article-title":"Serotonin as a developmental signal","volume":"73","author":"Whitaker-Azmitia","year":"1995","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.biopha.2020.110776_bib0680","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.neubiorev.2018.06.022","article-title":"Modulation of glucocorticoids by the serotonin transporter polymorphism: a narrative review","volume":"92","author":"Gunnewiek","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.biopha.2020.110776_bib0685","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neubiorev.2016.04.005","article-title":"Neurobiological markers predicting treatment response in anxiety disorders: a systematic review and implications for clinical application","volume":"66","author":"Lueken","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"10","key":"10.1016\/j.biopha.2020.110776_bib0690","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/cercor\/bhh070","article-title":"Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex","volume":"14","author":"Santana","year":"2004","journal-title":"Cereb. Cortex"},{"issue":"47","key":"10.1016\/j.biopha.2020.110776_bib0695","doi-asserted-by":"crossref","first-page":"10831","DOI":"10.1523\/JNEUROSCI.2999-05.2005","article-title":"Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action","volume":"25","author":"D\u00edaz-Mataix","year":"2005","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.biopha.2020.110776_bib0700","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/WNR.0b013e3283614cbf","article-title":"5-Hydroxytryptamine 1A receptors inhibit glutamate release in rat medullary dorsal horn neurons","volume":"24","author":"Choi","year":"2013","journal-title":"Neuroreport"},{"issue":"4","key":"10.1016\/j.biopha.2020.110776_bib0705","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0022-510X(71)90178-X","article-title":"Monoamines in the human neostriatum: topographic distribution in normals and in Parkinson\u2019s disease and their role in akinesia, rigidity, chorea, and tremor","volume":"14","author":"Fahn","year":"1971","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2020.110776_bib0710","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0006-8993(83)90993-9","article-title":"Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson\u2019s disease","volume":"275","author":"Scatton","year":"1983","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.biopha.2020.110776_bib0715","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0006-8993(94)91761-2","article-title":"Noradrenaline, dopamine and serotonin levels and metabolism in the human hypothalamus: observations in Parkinson\u2019s disease and normal subjects","volume":"639","author":"Shannak","year":"1994","journal-title":"Brain Res."},{"issue":"Pt 9","key":"10.1016\/j.biopha.2020.110776_bib0720","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1093\/brain\/aww162","article-title":"The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson\u2019s disease","volume":"139","author":"Maillet","year":"2016","journal-title":"Brain: J. Neurol."},{"issue":"8","key":"10.1016\/j.biopha.2020.110776_bib0725","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1017\/S1092852900001358","article-title":"Role of norepinephrine in the pathophysiology of neuropsychiatric disorders","volume":"6","author":"Ressler","year":"2001","journal-title":"CNS Spectr."},{"issue":"5","key":"10.1016\/j.biopha.2020.110776_bib0730","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1046\/j.1460-9568.2003.02510.x","article-title":"\u03b12A and \u03b12C\u2010adrenoceptor regulation in the brain: \u03b12A changes persist after chronic stress","volume":"17","author":"Fl\u00fcgge","year":"2003","journal-title":"Eur. J. Neurosci."},{"issue":"3","key":"10.1016\/j.biopha.2020.110776_bib0735","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0165-0173(82)90010-8","article-title":"The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat","volume":"4","author":"Sawchenko","year":"1982","journal-title":"Brain Res. Rev."},{"issue":"4","key":"10.1016\/j.biopha.2020.110776_bib0740","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1210\/edrv.22.4.0436","article-title":"Stressor specificity of central neuroendocrine responses: implications for stress-related disorders","volume":"22","author":"Pacak","year":"2001","journal-title":"Endocr. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2020.110776_bib0745","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0165-0173(03)00143-7","article-title":"The locus coeruleus\u2013noradrenergic system: modulation of behavioral state and state-dependent cognitive processes","volume":"42","author":"Berridge","year":"2003","journal-title":"Brain Res. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2020.110776_bib0750","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.brainresrev.2008.11.001","article-title":"Autism, fever, epigenetics and the locus coeruleus","volume":"59","author":"Mehler","year":"2009","journal-title":"Brain Res. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2020.110776_bib0755","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF00495294","article-title":"Evidence for local corticotropin releasing factor (CRF)-immunoreactive neuronal circuits in the paraventricular nucleus of the rat hypothalamus","volume":"83","author":"Liposits","year":"1985","journal-title":"Histochemistry"},{"issue":"3","key":"10.1016\/j.biopha.2020.110776_bib0760","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF00495783","article-title":"Adrenergic innervation of corticotropin releasing factor (CRF)\u2014synthesizing neurons in the hypothalamic paraventricular nucleus of the rat","volume":"84","author":"Liposits","year":"1986","journal-title":"Histochemistry"},{"issue":"2","key":"10.1016\/j.biopha.2020.110776_bib0765","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.brainresrev.2007.04.005","article-title":"The stress system in depression and neurodegeneration: focus on the human hypothalamus","volume":"57","author":"Bao","year":"2008","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.biopha.2020.110776_bib0770","series-title":"Ciba Foundation Symposium 172\u2010Corticotropin\u2010Releasing Factor: Corticotropin\u2010Releasing Factor: Ciba Foundation Symposium 172","first-page":"5","article-title":"The functional neuroanatomy of corticotropin\u2010releasing factor","author":"Sawchenko","year":"2007"},{"key":"10.1016\/j.biopha.2020.110776_bib0775","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1146\/annurev.neuro.28.061604.135709","article-title":"An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance","volume":"28","author":"Aston-Jones","year":"2005","journal-title":"Annu. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2020.110776_bib0780","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresrev.2007.10.013","article-title":"Noradrenergic modulation of arousal","volume":"58","author":"Berridge","year":"2008","journal-title":"Brain Res. Rev."},{"issue":"11","key":"10.1016\/j.biopha.2020.110776_bib0785","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.tins.2005.09.002","article-title":"Network reset: a simplified overarching theory of locus coeruleus noradrenaline function","volume":"28","author":"Bouret","year":"2005","journal-title":"Trends Neurosci."},{"issue":"9","key":"10.1016\/j.biopha.2020.110776_bib0790","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/nn1944","article-title":"Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic","volume":"10","author":"Ressler","year":"2007","journal-title":"Nat. Neurosci."},{"issue":"8","key":"10.1016\/j.biopha.2020.110776_bib0795","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.pnpbp.2005.08.007","article-title":"Role of brain norepinephrine in the behavioral response to stress","volume":"29","author":"Morilak","year":"2005","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.biopha.2020.110776_bib0800","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.psc.2009.05.004","article-title":"The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology","volume":"32","author":"Martin","year":"2009","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.biopha.2020.110776_bib0805","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.neubiorev.2018.09.023","article-title":"Cortisol and alpha-amylase assessment in psychotherapeutic intervention studies: a systematic review","volume":"95","author":"Laufer","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"35","key":"10.1016\/j.biopha.2020.110776_bib0810","doi-asserted-by":"crossref","first-page":"5663","DOI":"10.2174\/138161212803530907","article-title":"The role of life events and HPA axis in anxiety disorders: a review","volume":"18","author":"Faravelli","year":"2012","journal-title":"Curr. Pharm. Des."},{"issue":"4","key":"10.1016\/j.biopha.2020.110776_bib0815","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/026988119100500414","article-title":"5-HT and mechanisms of defence","volume":"5","author":"Deakin","year":"1991","journal-title":"J. Psychopharmacol."},{"issue":"Supl I","key":"10.1016\/j.biopha.2020.110776_bib0820","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1590\/S1516-44462007000500002","article-title":"Ansiedade, p\u00e2nico e o eixo hipot\u00e1lamo-pituit\u00e1ria-adrenal Anxiety, panic and the hypothalamic-pituitary-adrenal axis","volume":"29","author":"Graeff","year":"2007","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.biopha.2020.110776_bib0825","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1749-6632.1997.tb52357.x","article-title":"Regulation of 5-HT receptors and the hypothalamic-pituitary-adrenal axis. Implications for the neurobiology of suicide","volume":"836","author":"Lopez","year":"1997","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2020.110776_bib0830","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1192\/bjp.179.5.390","article-title":"New insights into the role of the GABA A\u2013benzodiazepine receptor in psychiatric disorder","volume":"179","author":"Nutt","year":"2001","journal-title":"Br. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.biopha.2020.110776_bib0835","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/(SICI)1520-6394(1996)4:3<100::AID-DA2>3.0.CO;2-K","article-title":"Role of GABA in memory and anxiety","volume":"4","author":"Kalueff","year":"1996","journal-title":"Depress. Anxiety"},{"issue":"5","key":"10.1016\/j.biopha.2020.110776_bib0840","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0197-0186(99)00045-5","article-title":"Structure and subunit composition of GABAA receptors","volume":"34","author":"Sieghart","year":"1999","journal-title":"Neurochem. Int."},{"issue":"8","key":"10.1016\/j.biopha.2020.110776_bib0845","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.bcp.2004.07.023","article-title":"\u03b3-Aminobutyric acid A receptor subunit mutant mice: new perspectives on alcohol actions","volume":"68","author":"Boehm","year":"2004","journal-title":"Biochem. Pharmacol."},{"issue":"8","key":"10.1016\/j.biopha.2020.110776_bib0850","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.bcp.2004.07.026","article-title":"Fishing for allosteric sites on GABAA receptors","volume":"68","author":"Olsen","year":"2004","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110776_bib0855","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.tips.2004.11.004","article-title":"Don\u2019t worry \u2018B\u2019happy!: a role for GABAB receptors in anxiety and depression","volume":"26","author":"Cryan","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2020.110776_bib0860","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.biopsych.2003.08.009","article-title":"Low posttrauma GABA plasma levels as a predictive factor in the development of acute posttraumatic stress disorder","volume":"55","author":"Vaiva","year":"2004","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.biopha.2020.110776_bib0865","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/1756285613495723","article-title":"Anxiety in Parkinson\u2019s disease: identification and management","volume":"7","author":"Chen","year":"2014","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"5","key":"10.1016\/j.biopha.2020.110776_bib0870","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1600-0447.2001.00372.x","article-title":"Increased risk of developing Parkinson\u2019s disease for patients with major affective disorder: a register study","volume":"104","author":"Nilsson","year":"2001","journal-title":"Acta Psychiatr. Scand."},{"issue":"3","key":"10.1016\/j.biopha.2020.110776_bib0875","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4103\/aian.AIAN_241_17","article-title":"Levodopa: history and therapeutic applications","volume":"20","author":"Ovallath","year":"2017","journal-title":"Ann. Indian Acad. Neurol."},{"issue":"7","key":"10.1016\/j.biopha.2020.110776_bib0880","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/FBP.0b013e32833e7e80","article-title":"Behavioral and neurochemical effects of chronic L-DOPA treatment on non-motor sequelae in the hemiparkinsonian rat","volume":"21","author":"Jaunarajs","year":"2010","journal-title":"Behav. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110776_bib0885","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.pharmthera.2006.08.004","article-title":"Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission","volume":"113","author":"Alex","year":"2007","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2020.110776_bib0890","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13041-017-0306-y","article-title":"The role of 5-HT receptors in depression","volume":"10","author":"Yohn","year":"2017","journal-title":"Mol. Brain"},{"issue":"5","key":"10.1016\/j.biopha.2020.110776_bib0895","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1176\/ajp.149.5.719-c","article-title":"Anxiety disorders and Parkinson\u2019s disease","volume":"149","author":"Iruela","year":"1992","journal-title":"Am. J. Psychiatry"},{"issue":"47","key":"10.1016\/j.biopha.2020.110776_bib0900","doi-asserted-by":"crossref","first-page":"e300","DOI":"10.3346\/jkms.2018.33.e300","article-title":"Psychiatric manifestation in patients with parkinson\u2019s disease","volume":"33","author":"Han","year":"2018","journal-title":"J. Korean Med. Sci."},{"issue":"9","key":"10.1016\/j.biopha.2020.110776_bib0905","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/mds.26199","article-title":"Selective dysfunction of basal ganglia subterritories: from movement to behavioral disorders","volume":"30","author":"Tremblay","year":"2015","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.biopha.2020.110776_bib0910","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0887-6185(02)00225-6","article-title":"Quality of life and the anxiety disorders","volume":"17","author":"Quilty","year":"2003","journal-title":"J. Anxiety Disord."},{"key":"10.1016\/j.biopha.2020.110776_bib0915","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.neubiorev.2018.10.019","article-title":"Neural mechanisms of emotion regulation and their role in endocrine and immune functioning: a review with implications for treatment of affective disorders","volume":"95","author":"Lopez","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2020.110776_bib0920","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jns.2011.11.002","article-title":"Impact of complications and comorbidities on treatment costs and health-related quality of life of patients with Parkinson\u2019s disease","volume":"314","author":"Bach","year":"2012","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2020.110776_bib0925","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/mds.25664","article-title":"Health\u2010related quality of life in early Parkinson\u2019s disease: the impact of nonmotor symptoms","volume":"29","author":"Duncan","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.biopha.2020.110776_bib0930","article-title":"Relationships among depression, anxiety, sleep, and quality of life in patients with Parkinson\u2019s disease in Taiwan","volume":"2016","author":"Fan","year":"2016","journal-title":"Parkinsons Dis."},{"issue":"9","key":"10.1016\/j.biopha.2020.110776_bib0935","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137081","article-title":"Heterogeneous determinants of quality of life in different phenotypes of Parkinson\u2019s disease","volume":"10","author":"Fereshtehnejad","year":"2015","journal-title":"PLoS One"},{"issue":"15","key":"10.1016\/j.biopha.2020.110776_bib0940","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1002\/mds.23394","article-title":"What are the most important nonmotor symptoms in patients with Parkinson\u2019s disease and are we missing them?","volume":"25","author":"Gallagher","year":"2010","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/j.biopha.2020.110776_bib0945","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.parkreldis.2014.07.004","article-title":"Severity of mild cognitive impairment in early Parkinson\u2019s disease contributes to poorer quality of life","volume":"20","author":"Lawson","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"issue":"5","key":"10.1016\/j.biopha.2020.110776_bib0950","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/ageing\/afr078","article-title":"Behavioural disorders, disability and quality of life in Parkinson\u2019s disease","volume":"40","author":"Leroi","year":"2011","journal-title":"Age Ageing"},{"issue":"2","key":"10.1016\/j.biopha.2020.110776_bib0955","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1600-0404.2004.00292.x","article-title":"Mortality in Parkinson\u2019s disease and its association with dementia and depression","volume":"110","author":"Hughes","year":"2004","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.biopha.2020.110776_bib0960","article-title":"Anxiety and Parkinson\u2019s disease","author":"Richard","year":"1996","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.biopha.2020.110776_bib0965","doi-asserted-by":"crossref","DOI":"10.1097\/00004850-198801000-00005","article-title":"Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder: a double-blind comparative study with fluvoxamine and maprotiline","author":"den Boer","year":"1988","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"8","key":"10.1016\/j.biopha.2020.110776_bib0970","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1176\/ajp.144.8.1059","article-title":"Treatment of severe obsessive-compulsive disorder with fluvoxamine","volume":"144","author":"Price","year":"1987","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.biopha.2020.110776_bib0975","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1139\/y89-017","article-title":"Electrophysiological assessment of putative antagonists of 5-hydroxytryptamine receptors: a single-cell study in the rat dorsal raphe nucleus","volume":"67","author":"Blier","year":"1989","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"7","key":"10.1016\/j.biopha.2020.110776_bib0980","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1001\/archpsyc.1989.01810070051009","article-title":"Effects of desipramine and fluvoxamine treatment on the prolactin response to tryptophan: serotonergic function and the mechanism of antidepressant action","volume":"46","author":"Price","year":"1989","journal-title":"Arch. Gen. Psychiatry"},{"issue":"11","key":"10.1016\/j.biopha.2020.110776_bib0985","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079510","article-title":"A meta-analysis of randomised placebo-controlled treatment trials for depression and anxiety in Parkinson\u2019s disease","volume":"8","author":"Troeung","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biopha.2020.110776_bib0990","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/da.22854","article-title":"Systematic review and meta\u2010analysis: dose\u2013response curve of SSRIs and SNRIs in anxiety disorders","volume":"36","author":"Jakubovski","year":"2019","journal-title":"Depress. Anxiety"},{"issue":"1","key":"10.1016\/j.biopha.2020.110776_bib0995","first-page":"22","article-title":"SSRI antidepressant medications: adverse effects and tolerability","volume":"3","author":"Ferguson","year":"2001","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.biopha.2020.110776_bib1000","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1191\/1740774506cn139oa","article-title":"Do antidepressants cause suicidality in children? A Bayesian meta-analysis","volume":"3","author":"Kaizar","year":"2006","journal-title":"Clin. Trials"},{"issue":"6","key":"10.1016\/j.biopha.2020.110776_bib1005","first-page":"205","article-title":"Selecting a selective serotonin reuptake inhibitor: clinically important distinguishing features","volume":"2","author":"Marken","year":"2000","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.biopha.2020.110776_bib1010","first-page":"168","article-title":"Steps following attainment of remission: discontinuation of antidepressant therapy","volume":"3","author":"Shelton","year":"2001","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.biopha.2020.110776_bib1015","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0091-3057(88)90214-6","article-title":"The relative efficacy of buspirone, imipramine and placebo in panic disorder: a preliminary report","volume":"29","author":"Sheenan","year":"1988","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.biopha.2020.110776_bib1020","doi-asserted-by":"crossref","DOI":"10.1097\/00002826-199402000-00008","article-title":"Buspirone in levodopa-induced dyskinesias","author":"Bonifati","year":"1994","journal-title":"Clin. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110776_bib1025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/syn.890010103","article-title":"Electrophysiological responses of serotoninergic dorsal raphe neurons to 5\u2010HT1A and 5\u2010HT1B agonists","volume":"1","author":"Sprouse","year":"1987","journal-title":"Synapse"},{"issue":"1\u20134","key":"10.1016\/j.biopha.2020.110776_bib1030","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ddr.430080124","article-title":"Thymosthenic effects of ritanserin (R 55667), a centrally acting serotonin\u2010S2 receptor blocker","volume":"8","author":"Reyntjens","year":"1986","journal-title":"Drug Dev. Res."},{"issue":"9","key":"10.1016\/j.biopha.2020.110776_bib1035","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1096\/fasebj.2.9.2836252","article-title":"Buspirone, a new approach to the treatment of anxiety","volume":"2","author":"Taylor","year":"1988","journal-title":"Faseb J."},{"issue":"5","key":"10.1016\/j.biopha.2020.110776_bib1040","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1001\/archpsyc.1988.01800290060008","article-title":"Long-term treatment of anxiety and risk of withdrawal: prospective comparison of clorazepate and buspirone","volume":"45","author":"Rickels","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.biopha.2020.110776_bib1045","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.v60n0805","article-title":"Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder","author":"Davidson","year":"1999","journal-title":"J. Clin. Psychiatry"},{"issue":"11","key":"10.1016\/j.biopha.2020.110776_bib1050","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.4088\/JCP.08m04485blu","article-title":"Next-step strategies for panic disorder refractory to initial pharmacotherapy","volume":"70","author":"Simon","year":"2009","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.biopha.2020.110776_bib1055","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1590\/S0004-282X2000000600008","article-title":"Double-blind clonazepam vs placebo in panic disorder treatment","volume":"58","author":"Valenca","year":"2000","journal-title":"Arq. Neuropsiquiatr."},{"issue":"3","key":"10.1016\/j.biopha.2020.110776_bib1060","first-page":"326","article-title":"Treatment of anxiety in Parkinson\u2019s disease with bromazepam","volume":"45","author":"Casacchia","year":"1975","journal-title":"Riv. Neurol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110776_bib1065","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0887-6185(02)00091-9","article-title":"Naturalistic manner of benzodiazepine use and cognitive behavioral therapy outcome in panic disorder with agoraphobia","volume":"16","author":"Westra","year":"2002","journal-title":"J. Anxiety Disord."},{"issue":"1","key":"10.1016\/j.biopha.2020.110776_bib1070","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-244X-7-18","article-title":"Combination of psychotherapy and benzodiazepines versus either therapy alone for panic disorder: a systematic review","volume":"7","author":"Watanabe","year":"2007","journal-title":"BMC Psychiatry"},{"issue":"2","key":"10.1016\/j.biopha.2020.110776_bib1075","doi-asserted-by":"crossref","DOI":"10.3390\/jcm7020017","article-title":"Benzodiazepines I: Upping the care on downers: the evidence of risks, benefits and alternatives","volume":"7","author":"Guina","year":"2018","journal-title":"J. Clin. Med."},{"issue":"5","key":"10.1016\/j.biopha.2020.110776_bib1080","first-page":"25","article-title":"Benzodiazepines for substance abusers","volume":"2","author":"Sattar","year":"2003","journal-title":"Curr. Psychiatr."},{"issue":"8","key":"10.1016\/j.biopha.2020.110776_bib1085","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.brat.2010.04.002","article-title":"Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: further evaluation","volume":"48","author":"Otto","year":"2010","journal-title":"Behav. Res. Ther."},{"issue":"3\u20134","key":"10.1016\/j.biopha.2020.110776_bib1090","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/10401230309085686","article-title":"Imiprmaine vs. sertraline in panic disorder: 24-week treatment completers","volume":"15","author":"Mavissakalian","year":"2003","journal-title":"Ann. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.biopha.2020.110776_bib1095","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1590\/S1516-44462005000100007","article-title":"The efficacy of antidepressants for generalized anxiety disorder: a systematic review and meta-analysis","volume":"27","author":"Schmitt","year":"2005","journal-title":"Brazilian Journal of Psychiatry"},{"issue":"5","key":"10.1016\/j.biopha.2020.110776_bib1100","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0006-3223(90)90408-T","article-title":"Clomipramine in obsessive-compulsive disorder","volume":"28","author":"Katz","year":"1990","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2020.110776_bib1105","article-title":"Mode of action of antidepressant drugs","author":"Sulser","year":"1983","journal-title":"J. Clin. Psychiatry"},{"issue":"8","key":"10.1016\/j.biopha.2020.110776_bib1110","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.janxdis.2012.07.009","article-title":"Pharmacological treatment of anxiety disorders: current treatments and future directions","volume":"26","author":"Farach","year":"2012","journal-title":"J. Anxiety Disord."},{"issue":"6","key":"10.1016\/j.biopha.2020.110776_bib1115","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000353198","article-title":"Efficacy and tolerability of benzodiazepines versus antidepressants in anxiety disorders: a systematic review and meta-analysis","volume":"82","author":"Offidani","year":"2013","journal-title":"Psychother. Psychosom."},{"issue":"1","key":"10.1016\/j.biopha.2020.110776_bib1120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5607\/en.2011.20.1.1","article-title":"MAO-inhibitors in parkinson\u2019s disease","volume":"20","author":"Riederer","year":"2011","journal-title":"Exp. Neurobiol."},{"issue":"3\u20134","key":"10.1016\/j.biopha.2020.110776_bib1125","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0278-5846(89)90137-1","article-title":"Common side effects associated with monoamine oxidase inhibitors","volume":"13","author":"Remick","year":"1989","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.biopha.2020.110776_bib1130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4103\/0019-5545.44910","article-title":"Hypertensive crisis and cheese","volume":"51","author":"Sathyanarayana Rao","year":"2009","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.biopha.2020.110776_bib1135","series-title":"Monoamine Oxidase Inhibitor Toxicity","author":"Garcia","year":"2020"},{"issue":"1","key":"10.1016\/j.biopha.2020.110776_bib1140","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.psychres.2004.05.012","article-title":"Association studies of MAO-A, COMT, and 5-HTT genes polymorphisms in patients with anxiety disorders of the phobic spectrum","volume":"128","author":"Samochowiec","year":"2004","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.biopha.2020.110776_bib1145","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3233\/JPD-150542","article-title":"Cognitive behaviour therapy for depression and anxiety in parkinson\u2019s disease","volume":"5","author":"Egan","year":"2015","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.biopha.2020.110776_bib1150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctcp.2020.101111","article-title":"Cognitive behavioral therapy for depression and anxiety of Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"39","author":"Zhang","year":"2020","journal-title":"Complement. Ther. Clin. Pract."},{"issue":"1","key":"10.1016\/j.biopha.2020.110776_bib1155","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/ebmh.11.1.5","article-title":"Cognitive-behavioural therapies: achievements and challenges","volume":"11","author":"Gaudiano","year":"2008","journal-title":"Evid. Ment. Health"},{"issue":"3","key":"10.1016\/j.biopha.2020.110776_bib1160","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.psc.2010.04.005","article-title":"Cognitive behavioral therapy for mood disorders: efficacy, moderators and mediators","volume":"33","author":"Driessen","year":"2010","journal-title":"Psychiatr. Clin. North Am."},{"issue":"18","key":"10.1016\/j.biopha.2020.110776_bib1165","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1212\/WNL.0000000000003279","article-title":"Multifocal repetitive TMS for motor and mood symptoms of Parkinson disease: a randomized trial","volume":"87","author":"Brys","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2020.110776_bib1170","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neubiorev.2015.08.010","article-title":"Transcranial direct current stimulation in Parkinson\u2019s disease: neurophysiological mechanisms and behavioral effects","volume":"57","author":"Broeder","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"6792","key":"10.1016\/j.biopha.2020.110776_bib1175","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/35018000","article-title":"Transcranial magnetic stimulation and the human brain","volume":"406","author":"Hallett","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2020.110776_bib1180","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.neubiorev.2017.11.018","article-title":"Assessing cerebellar brain inhibition (CBI) via transcranial magnetic stimulation (TMS): a systematic review","volume":"86","author":"Fernandez","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3","key":"10.1016\/j.biopha.2020.110776_bib1185","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1474-4422(03)00321-1","article-title":"Transcranial magnetic stimulation in neurology","volume":"2","author":"Kobayashi","year":"2003","journal-title":"Lancet Neurol."},{"issue":"8","key":"10.1016\/j.biopha.2020.110776_bib1190","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S1388-2457(01)00585-5","article-title":"Therapeutic application of repetitive transcranial magnetic stimulation: a review","volume":"112","author":"Wassermann","year":"2001","journal-title":"Clin. Neurophysiol."},{"issue":"5","key":"10.1016\/j.biopha.2020.110776_bib1195","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1176\/appi.ajp.160.5.835","article-title":"Transcranial magnetic stimulation in the treatment of depression","volume":"160","author":"Gershon","year":"2003","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.biopha.2020.110776_bib1200","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S1388-2457(03)00004-X","article-title":"Transcranial magnetic stimulation and epilepsy","volume":"114","author":"Tassinari","year":"2003","journal-title":"Clin. Neurophysiol."},{"issue":"18","key":"10.1016\/j.biopha.2020.110776_bib1205","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000019642","article-title":"Motor recovery and antidepressant effects of repetitive transcranial magnetic stimulation on Parkinson disease: a PRISMA-compliant meta-analysis","volume":"99","author":"Li","year":"2020","journal-title":"Medicine"},{"issue":"11","key":"10.1016\/j.biopha.2020.110776_bib1210","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/cercor\/bhl183","article-title":"Probing the pathophysiology of auditory\/verbal hallucinations by combining functional magnetic resonance imaging and transcranial magnetic stimulation","volume":"17","author":"Hoffman","year":"2007","journal-title":"Cereb. Cortex"},{"issue":"12","key":"10.1016\/j.biopha.2020.110776_bib1215","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1136\/jnnp.2005.069849","article-title":"Non-invasive brain stimulation for Parkinson\u2019s disease: a systematic review and meta-analysis of the literature","volume":"76","author":"Fregni","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.biopha.2020.110776_bib1220","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000086674","article-title":"Antiepileptic effects of repetitive transcranial magnetic stimulation in patients with cortical malformations: an EEG and clinical study","volume":"83","author":"Fregni","year":"2005","journal-title":"Stereotact. Funct. Neurosurg."},{"issue":"3","key":"10.1016\/j.biopha.2020.110776_bib1225","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/01616412.2000.11740668","article-title":"Mechanisms of deep brain stimulation and future technical developments","volume":"22","author":"Erwin","year":"2000","journal-title":"Neurol. Res."},{"issue":"1","key":"10.1016\/j.biopha.2020.110776_bib1230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.parkreldis.2006.03.001","article-title":"Deep brain stimulation in neurologic disorders","volume":"13","author":"Halpern","year":"2007","journal-title":"Parkinsonism Relat. Disord."},{"issue":"3","key":"10.1016\/j.biopha.2020.110776_bib1235","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.neubiorev.2007.06.003","article-title":"Mechanisms of action of deep brain stimulation (DBS)","volume":"32","author":"Montgomery","year":"2008","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"10","key":"10.1016\/j.biopha.2020.110776_bib1240","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1093\/brain\/awn214","article-title":"A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson\u2019s disease","volume":"131","author":"Voon","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.biopha.2020.110776_bib1245","series-title":"Rasayana: Ayurvedic Herbs for Longevity and Rejuvenation","author":"Puri","year":"2002"},{"issue":"2","key":"10.1016\/j.biopha.2020.110776_bib1250","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jep.2005.02.035","article-title":"Antioxidant approach to disease management and the role of \u2018Rasayana\u2019herbs of Ayurveda","volume":"99","author":"Govindarajan","year":"2005","journal-title":"J. Ethnopharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2020.110776_bib1255","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0944-7113(00)80030-6","article-title":"Anxiolytic-antidepressant activity of Withania somnifera glycowithanolides: an experimental study","volume":"7","author":"Bhattacharya","year":"2000","journal-title":"Phytomedicine: Int. J. Phytotherapy Phytopharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2020.110776_bib1260","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/01.psy.0000132877.72833.71","article-title":"Attenuation of laboratory-induced stress in humans after acute administration of Melissa officinalis (Lemon Balm)","volume":"66","author":"Kennedy","year":"2004","journal-title":"Psychosom. Med."},{"issue":"8","key":"10.1016\/j.biopha.2020.110776_bib1265","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0367-326X(01)00322-7","article-title":"Anxiolytic activity of aerial and underground parts of Passiflora incarnata","volume":"72","author":"Dhawan","year":"2001","journal-title":"Fitoterapia"},{"issue":"2","key":"10.1016\/j.biopha.2020.110776_bib1270","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1600-0773.1992.tb00530.x","article-title":"Kava pyrones and resin: studies on GABAA, GABAB and benzodiazepine binding sites in rodent brain","volume":"71","author":"Davies","year":"1992","journal-title":"Pharmacol. Toxicol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110776_bib1275","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0306-4522(97)00177-2","article-title":"Kava extract ingredients,(+)-methysticin and (\u00b1)-kavain inhibit voltage-operated Na+-channels in rat CA1 hippocampal neurons","volume":"81","author":"Magura","year":"1997","journal-title":"Neuroscience"},{"issue":"9\u201310","key":"10.1016\/j.biopha.2020.110776_bib1280","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.phymed.2006.01.011","article-title":"Evaluation of anxiolytic properties of Gotukola\u2013(Centella asiatica) extracts and asiaticoside in rat behavioral models","volume":"13","author":"Wijeweera","year":"2006","journal-title":"Phytomedicine: Int. J. Phytotherapy Phytopharmacol."},{"key":"10.1016\/j.biopha.2020.110776_bib1285","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S0367-326X(00)00180-5","article-title":"Ginkgo biloba and the central nervous system","volume":"71","author":"Di Renzo","year":"2000","journal-title":"Fitoterapia"},{"issue":"6","key":"10.1016\/j.biopha.2020.110776_bib1290","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jpsychires.2006.05.004","article-title":"Ginkgo biloba special extract EGb 761\u00ae in generalized anxiety disorder and adjustment disorder with anxious mood: a randomized, double-blind, placebo-controlled trial","volume":"41","author":"Woelk","year":"2007","journal-title":"J. Psychiatr. Res."},{"issue":"11","key":"10.1016\/j.biopha.2020.110776_bib1295","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/S0006-2952(00)00264-1","article-title":"Pharmacological profile of apigenin, a flavonoid isolated from Matricaria chamomilla","volume":"59","author":"Avallone","year":"2000","journal-title":"Biochem. Pharmacol."},{"issue":"9","key":"10.1016\/j.biopha.2020.110776_bib1300","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1139\/Y07-083","article-title":"Effects of traditionally used anxiolytic botanicals on enzymes of the \u03b3-aminobutyric acid (GABA) system","volume":"85","author":"Awad","year":"2007","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110776_bib1305","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1185\/030079903125002603","article-title":"Double-blind, randomised, placebo-controlled study to evaluate the efficacy and safety of a fixed combination containing two plant extracts (Crataegus oxyacantha and Eschscholtzia californica) and magnesium in mild-to-moderate anxiety disorders","volume":"20","author":"Hanus","year":"2004","journal-title":"Curr. Med. Res. Opin."},{"issue":"2","key":"10.1016\/j.biopha.2020.110776_bib1310","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.yebeh.2009.07.031","article-title":"Upregulation of 5-HT2C receptors in hippocampus of pilocarpine-induced epileptic rats: antagonism by Bacopa monnieri","volume":"16","author":"Krishnakumar","year":"2009","journal-title":"Epilepsy Behav. E&B"},{"issue":"3","key":"10.1016\/j.biopha.2020.110776_bib1315","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1078\/0944-7113-00116","article-title":"Antidepressant activity of standardized extract of Bacopa monniera in experimental models of depression in rats","volume":"9","author":"Sairam","year":"2002","journal-title":"Phytomedicine: Int. J. Phytotherapy Phytopharmacol."},{"issue":"13\u201314","key":"10.1016\/j.biopha.2020.110776_bib1320","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10354-007-0428-4","article-title":"Saffron in phytotherapy: pharmacology and clinical uses","volume":"157","author":"Schmidt","year":"2007","journal-title":"Wiener Med. Wochenschr."},{"issue":"6","key":"10.1016\/j.biopha.2020.110776_bib1325","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/ptr.2597","article-title":"Anxiolytic and hypnotic effect of Crocus sativus aqueous extract and its constituents, crocin and safranal, in mice","volume":"23","author":"Hosseinzadeh","year":"2009","journal-title":"Phytotherapy Res. PTR"},{"issue":"07","key":"10.1016\/j.biopha.2020.110776_bib1330","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1055\/s-2008-1074535","article-title":"Quality and functionality of saffron: quality control, species assortment and affinity of extract and isolated saffron compounds to NMDA and \u03c31 (sigma-1) receptors","volume":"74","author":"Lechtenberg","year":"2008","journal-title":"Planta Med."},{"issue":"9","key":"10.1016\/j.biopha.2020.110776_bib1335","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.phymed.2009.03.011","article-title":"The effects of Rhodiola rosea extract on 5-HT level, cell proliferation and quantity of neurons at cerebral hippocampus of depressive rats","volume":"16","author":"Chen","year":"2009","journal-title":"Phytomedicine: Int. J. Phytotherapy Phytopharmacol."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2020.110776_bib1340","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.phymed.2007.10.003","article-title":"Comparative study of Rhodiola preparations on behavioral despair of rats","volume":"15","author":"Panossian","year":"2008","journal-title":"Phytomedicine: Int. J. Phytotherapy Phytopharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110776_bib1345","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ptr.2013","article-title":"Adaptogenic and central nervous system effects of single doses of 3% rosavin and 1% salidroside Rhodiola rosea L. extract in mice","volume":"21","author":"Perfumi","year":"2007","journal-title":"Phytother. Res."},{"issue":"1","key":"10.1016\/j.biopha.2020.110776_bib1350","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.pbb.2005.03.014","article-title":"Effect of chronic Albizzia julibrissin treatment on 5-hydroxytryptamine1A receptors in rat brain","volume":"81","author":"Jung","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.biopha.2020.110776_bib1355","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.pbb.2007.03.018","article-title":"Antidepressant-like effects of Albizzia julibrissin in mice: involvement of the 5-HT1A receptor system","volume":"87","author":"Kim","year":"2007","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.biopha.2020.110776_bib1360","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jep.2006.12.021","article-title":"Anxiolytic effects of Lavandula angustifolia odour on the Mongolian gerbil elevated plus maze","volume":"111","author":"Bradley","year":"2007","journal-title":"J. Ethnopharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2020.110776_bib1365","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2165\/00023210-200620040-00001","article-title":"Aromatherapy in the management of psychiatric disorders","volume":"20","author":"Perry","year":"2006","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.biopha.2020.110776_bib1370","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.psychres.2005.12.012","article-title":"Smelling lavender and rosemary increases free radical scavenging activity and decreases cortisol level in saliva","volume":"150","author":"Atsumi","year":"2007","journal-title":"Psychiatry Res."},{"issue":"5","key":"10.1016\/j.biopha.2020.110776_bib1375","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.fitote.2004.04.004","article-title":"Anxiolytic effects of Echium amoenum on the elevated plus-maze model of anxiety in mice","volume":"75","author":"Rabbani","year":"2004","journal-title":"Fitoterapia"},{"issue":"8","key":"10.1016\/j.biopha.2020.110776_bib1380","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2165\/00023210-200317080-00001","article-title":"Mechanism of action of St John\u2019s wort in depression","volume":"17","author":"Butterweck","year":"2003","journal-title":"CNS Drugs"},{"issue":"1\u20133","key":"10.1016\/j.biopha.2020.110776_bib1385","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejphar.2010.02.035","article-title":"Hypericin, the active component of St. John\u2019s wort, inhibits glutamate release in the rat cerebrocortical synaptosomes via a mitogen-activated protein kinase-dependent pathway","volume":"634","author":"Chang","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2020.110776_bib1390","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jep.2016.08.020","article-title":"Management of Parkinson\u2019s disease in Ayurveda: medicinal plants and adjuvant measures","volume":"197","author":"Pathak-Gandhi","year":"2017","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2020.110776_bib1395","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1016\/S1353-8020(11)70036-0","article-title":"Rehabilitation, exercise therapy and music in patients with Parkinson\u2019s disease: a meta-analysis of the effects of music-based movement therapy on walking ability, balance and quality of life","volume":"18","author":"de Dreu","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.biopha.2020.110776_bib1400","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.aip.2015.02.003","article-title":"Music therapy in generalized anxiety disorder","volume":"44","author":"Guti\u00e9rrez","year":"2015","journal-title":"Arts Psychother."},{"issue":"4","key":"10.1016\/j.biopha.2020.110776_bib1405","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/jmt\/38.4.273","article-title":"Effects of a music therapy voice protocol on speech intelligibility, vocal acoustic measures, and mood of individuals with Parkinson\u2019s disease","volume":"38","author":"Haneishi","year":"2001","journal-title":"J. Music Ther."},{"issue":"4","key":"10.1016\/j.biopha.2020.110776_bib1410","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ypmed.2005.12.002","article-title":"Regular exercise, anxiety, depression and personality: a population-based study","volume":"42","author":"De Moor","year":"2006","journal-title":"Prev. Med."},{"issue":"1","key":"10.1016\/j.biopha.2020.110776_bib1415","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/acm.2009.0044","article-title":"The health benefits of yoga and exercise: a review of comparison studies","volume":"16","author":"Ross","year":"2010","journal-title":"J. Altern. Complement. Med."},{"issue":"2","key":"10.1016\/j.biopha.2020.110776_bib1420","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ctcp.2009.01.003","article-title":"Effects of yoga on depression and anxiety of women","volume":"15","author":"Javnbakht","year":"2009","journal-title":"Complement. Ther. Clin. Pract."},{"issue":"7","key":"10.1016\/j.biopha.2020.110776_bib1425","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1001\/jamaneurol.2019.0534","article-title":"Effects of mindfulness yoga vs stretching and resistance training exercises on anxiety and depression for people with parkinson disease: a randomized clinical trial","volume":"76","author":"Kwok","year":"2019","journal-title":"JAMA Neurol."},{"issue":"4","key":"10.1016\/j.biopha.2020.110776_bib1430","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1177\/070674370705200409","article-title":"Does mindfulness meditation improve anxiety and mood symptoms? A review of the controlled research","volume":"52","author":"Toneatto","year":"2007","journal-title":"Can. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.biopha.2020.110776_bib1435","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.mcna.2017.04.004","article-title":"Complementary therapies for mental health disorders","volume":"101","author":"Asher","year":"2017","journal-title":"Med. Clin. North Am."},{"issue":"1","key":"10.1016\/j.biopha.2020.110776_bib1440","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/YCO.0b013e3282f2d814","article-title":"Complementary and alternative medicine in the treatment of anxiety and depression","volume":"21","author":"van der Watt","year":"2008","journal-title":"Curr. Opin. Psychiatry"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220309690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220309690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T18:44:10Z","timestamp":1766083450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220309690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":288,"alternative-id":["S0753332220309690"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110776","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anxiety: An ignored aspect of Parkinson\u2019s disease lacking attention","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110776","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"110776"}}